These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
317 related items for PubMed ID: 33834345
1. Multimodal imaging characteristics in eyes with vitreoretinal lymphoma treated with intravitreal rituximab. Rishi P, Maitra P, Das K, Rishi E, Manchegowda PT. Int Ophthalmol; 2021 Aug; 41(8):2711-2722. PubMed ID: 33834345 [Abstract] [Full Text] [Related]
2. Retinal and Choroidal Changes of Vitreoretinal Lymphoma from Active to Remission Phase after Intravitreal Rituximab. Cicinelli MV, Marchese A, Miserocchi E, Giuffré C, Berchicci L, Querques G, Bandello F, Modorati GM. Ocul Immunol Inflamm; 2020 May 18; 28(4):637-646. PubMed ID: 31393199 [Abstract] [Full Text] [Related]
3. Intravitreal rituximab monotherapy for management of eyes with vitreoretinal lymphoma: initial experience from India. Rishi P, Manchegowda PT, Gondhale HP, Rishi E, Das K, Krishnakumar S, Raja T, Biswas J. Int Ophthalmol; 2021 Jul 18; 41(7):2495-2504. PubMed ID: 33730314 [Abstract] [Full Text] [Related]
6. Optical coherence tomography features in vitreoretinal lymphoma compared with non-infectious uveitis. El Zein L, Smith WM, White LJ, Hodge DO, Olsen TW, Pulido JS, Dalvin LA. BMC Ophthalmol; 2024 Jun 13; 24(1):255. PubMed ID: 38872120 [Abstract] [Full Text] [Related]
7. Fundus autofluorescence patterns in primary intraocular lymphoma. Casady M, Faia L, Nazemzadeh M, Nussenblatt R, Chan CC, Sen HN. Retina; 2014 Feb 13; 34(2):366-72. PubMed ID: 23958842 [Abstract] [Full Text] [Related]
8. REGRESSION OF TYPE 2 NEOVASCULARIZATION INTO A TYPE 1 PATTERN AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. Dolz-Marco R, Phasukkijwatana N, Sarraf D, Freund KB. Retina; 2017 Feb 13; 37(2):222-233. PubMed ID: 27627752 [Abstract] [Full Text] [Related]
9. Acute Sterile Endophthalmitis Following Intravitreal Rituximab Injection in Primary Vitreoretinal Lymphoma: Case Series. Guneri Beser B, Demirci H. Ocul Immunol Inflamm; 2024 Aug 13; 32(6):863-868. PubMed ID: 36952513 [Abstract] [Full Text] [Related]
10. Tumor Control and Visual Acuity Outcomes in Vitreoretinal Lymphoma with and without Sub-Retinal Pigment Epithelium Infiltration: Analysis of 125 Eyes of 70 Patients at a Single Ocular Oncology Center. Dalvin LA, Lim LS, Ancona-Lezama D, Mazloumi M, Chang M, Mashayekhi A, Shields CL. Ophthalmol Retina; 2019 Nov 13; 3(11):998-1005. PubMed ID: 31358444 [Abstract] [Full Text] [Related]
11. OPTICAL COHERENCE TOMOGRAPHY PREDICTORS OF SHORT-TERM VISUAL ACUITY IN EYES WITH MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION TREATED WITH INTRAVITREAL CONBERCEPT. Tang F, Qin X, Lu J, Song P, Li M, Ma X. Retina; 2020 Apr 13; 40(4):773-785. PubMed ID: 30640282 [Abstract] [Full Text] [Related]
13. Multimodal Imaging of Vitreoretinal Lymphoma. Mapelli C, Invernizzi A, Barteselli G, Pellegrini M, Tabacchi E, Staurenghi G, Viola F. Ophthalmologica; 2016 Jun 13; 236(3):166-174. PubMed ID: 27627063 [Abstract] [Full Text] [Related]
14. A comprehensive overview of diagnosis, imaging and treatment of vitreoretinal lymphoma. Menean M, Giuffrè C, Cicinelli MV, Marchese A, Modorati G, Bandello F, Miserocchi E. Eur J Ophthalmol; 2024 Jul 13; 34(4):931-940. PubMed ID: 37956540 [Abstract] [Full Text] [Related]
15. Swept-source optical coherence tomography angiography findings in a case of primary vitreoretinal lymphoma over a three-year follow-up. Maggio E, Bauci F, Polito A, Arena F, Pertile G. BMC Ophthalmol; 2024 Apr 25; 24(1):194. PubMed ID: 38664667 [Abstract] [Full Text] [Related]
16. The Silent Masquerade: Clinical and Imaging Features of Asymptomatic Vitreoretinal Lymphoma. Menean M, Cicinelli MV, Rivolta MC, Marchese A, Modorati G, Bandello F, Miserocchi E. Am J Ophthalmol; 2024 Nov 25; 267():153-159. PubMed ID: 38977150 [Abstract] [Full Text] [Related]
17. Clinical Experience in a Large Cohort of Patients with Vitreoretinal Lymphoma in a Single Center. Giuffrè C, Cicinelli MV, Marchese A, Modorati GM, Brambati M, Ferreri AJM, Calimeri T, Ponzoni M, Bandello F, Miserocchi E. Ocul Immunol Inflamm; 2021 Apr 03; 29(3):472-478. PubMed ID: 32845738 [Abstract] [Full Text] [Related]
18. Paraneoplastic cloudy vitelliform submaculopathy in primary vitreoretinal lymphoma. Pang CE, Shields CL, Jumper JM, Yannuzzi LA. Am J Ophthalmol; 2014 Dec 03; 158(6):1253-1261.e2. PubMed ID: 25174893 [Abstract] [Full Text] [Related]
19. Spectral-domain optical coherence tomography biomarkers in vitreoretinal lymphoma. Guan W, Xiao Y, Zhao H, Hu F, Chen C, Peng X. Clin Exp Ophthalmol; 2023 Mar 03; 51(2):144-153. PubMed ID: 36567492 [Abstract] [Full Text] [Related]
20. Familial Exudative Vitreoretinopathy: Spectral-Domain Optical Coherence Tomography of the Vitreoretinal Interface, Retina, and Choroid. Yonekawa Y, Thomas BJ, Drenser KA, Trese MT, Capone A. Ophthalmology; 2015 Nov 03; 122(11):2270-7. PubMed ID: 26299697 [Abstract] [Full Text] [Related] Page: [Next] [New Search]